ABSTRACT
COVID-19 has brought to center stage the most important health issue of our era, largely ignored by policymakers and the public to date: non-communicable diseases (NCDs), the cause of 71% of deaths per year worldwide. People living with NCDs, and particularly those living with cardiovascular disease (CVD), are at higher risk of severe symptoms and death from COVID-19. As a result, the urgent need for policy measures to protect cardiovascular health is more apparent than ever. One example of "low-hanging fruit" in the prevention of CVD is the elimination of industrially-produced trans fatty acids (iTFA). Their removal from the global food supply could prevent up to 17 million deaths by 2040 and would be the first time an NCD risk factor has been eliminated.
ABSTRACT
Over the years, the main European institutions active in health [European Union, and the Regional Office for Europe of the World Health Organization (WHO)] have played active roles in policy for public health in Europe. Yet, more recent developments have called into question the place of public health on the European political agenda. In this article, we reflect on how European health policy is set and what the role of civil society organizations (CSOs) can or should be, by showcasing two European associations as examples of how to influence European health policy development and implementation.
